Ryan Alexander Jones
CIK: 0002007219
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYTX
Kyverna Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Jones Ryan Alexander
Jones Ryan Alexander (SEC CIK 0002007219) files insider reports with the SEC as Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX).
Signal8 holds 1 ownership filing by Jones Ryan Alexander, a Form 4, filed on Apr 15, 2025. Those filings report 2 transactions, from Apr 11, 2024 to Apr 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Jones Ryan Alexander's filings is in EMERYVILLE, CA.
Recent filings by Jones Ryan Alexander
Other insiders filing for Kyverna Therapeutics, Inc. (KYTX)
- CLARK IAN T, Director
- Cohen Fred E, Director
- SEIDENBERG BETH C, Director
- Shaw Christi, Executive Chairperson
- Aktar Mert, Director
- Martini Gregory S., Chief Financial Officer